These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5516579)

  • 21. Interferons.
    Higgins PG
    J Clin Pathol; 1984 Feb; 37(2):109-16. PubMed ID: 6198337
    [No Abstract]   [Full Text] [Related]  

  • 22. Properties of the intracytoplasmic A particles purified from mouse tumors.
    Tanaka H; Tamura A; Tsujimura D
    Virology; 1972 Jul; 49(1):61-78. PubMed ID: 4114180
    [No Abstract]   [Full Text] [Related]  

  • 23. GROWTH CHARACTERISTICS, VIRUS YIELD, AND INTERFERON ASSAY OF LEUKEMIC MOUSE SPLEEN TISSUE CULTURES.
    SINKOVICS JG; HOWE CD
    J Infect Dis; 1964 Oct; 114():359-72. PubMed ID: 14217936
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tumor immunology].
    Gallmeier WM; Oettgen HF
    Dtsch Med Wochenschr; 1968 May; 93(22):1114-8. PubMed ID: 4297719
    [No Abstract]   [Full Text] [Related]  

  • 25. Interferon and murine leukemia. V. Effect of interferon preparations on the evolution of Rauscher disease in mice.
    Gresser I; Berman L; De Thé G; Brouty-Boyé D; Coppey J; Falcoff E
    J Natl Cancer Inst; 1968 Aug; 41(2):505-22. PubMed ID: 5671288
    [No Abstract]   [Full Text] [Related]  

  • 26. [The problem of inclusion bodies in tumors. I. Animals].
    Guérin M
    Bull Cancer; 1967; 54(3):263-84. PubMed ID: 4296627
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppression of established Friend virus leukemia by statolon. 3. Development of FV-leukemogenic and FV-immunogenic activities in bloods, spleens, and lymph nodes.
    Wheelock EF; Caroline NL; Moore RD
    J Natl Cancer Inst; 1971 Apr; 46(4):797-802. PubMed ID: 5103314
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of exogenous and endogenous interferons on the course of leukemia induced by Friend virus in mice].
    Sadashvili MK; Furer NM
    Antibiotiki; 1970 Jan; 15(1):52-5. PubMed ID: 4909951
    [No Abstract]   [Full Text] [Related]  

  • 29. Intramitochondrial bodies in a human cell line carrying oncornavirus-like particles.
    Keydar J; Braslawsky G; Dajbog T; Karby S; Shinedling ST; Weiss F; Delarea J
    J Natl Cancer Inst; 1975 Jan; 54(1):247-9. PubMed ID: 1167594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. 43.
    Schepartz SA; Abbott BJ; Leiter J
    Cancer Res; 1967 Aug; 27(8 Pt 2):737-920. PubMed ID: 6050920
    [No Abstract]   [Full Text] [Related]  

  • 31. Biologic and morphologic analysis of growth and cellular pattern of tissues from mice with viral leukemia cultured in vitro.
    Niezabitowski A
    Acta Med Pol; 1969; 10(4):389-400. PubMed ID: 4312598
    [No Abstract]   [Full Text] [Related]  

  • 32. [PS viruses and tumors. Multiplication in tissue cultures of an oncogenic agent from an early radioleukosis].
    Mouriquand J; Mouriquand C
    Ann Inst Pasteur (Paris); 1966 Aug; 111(2):113-24. PubMed ID: 5969251
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of prolonged interferon treatment on mouse embryonic fibroblasts transformed by murine sarcoma virus.
    Chany C; Vignal M
    J Gen Virol; 1970 Jun; 7(3):203-10. PubMed ID: 5466001
    [No Abstract]   [Full Text] [Related]  

  • 34. Leukemia induction in C3H mice following their inoculation with normal AKR lymphoid cells.
    Nemirovsky T; Trainin N
    Int J Cancer; 1973 Jan; 11(1):172-7. PubMed ID: 4151449
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of synthetic interferon-inducers on malignant tumors and viral oncogenesis].
    Vopr Virusol; 1970; 15(2):247-9. PubMed ID: 4919240
    [No Abstract]   [Full Text] [Related]  

  • 36. Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus.
    Nowinski RC; Old LJ; Boyse EA; de Harven E; Geering G
    Virology; 1968 Apr; 34(4):617-29. PubMed ID: 4297122
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunological and chemotherapeutic prevention and control of oncogenic viruses.
    Chirigos MA; Papas TS
    Adv Pharmacol Chemother; 1975; 12(0):89-124. PubMed ID: 50721
    [No Abstract]   [Full Text] [Related]  

  • 38. Viruses as possible etiologic factors in human breast cancer.
    Dmochowski L; Seman G; Gallager HS
    Cancer; 1969 Dec; 24(6):1241-9. PubMed ID: 4311118
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucan induced inhibition of tumor growth and enhancement of survival in a variety of transplantable and spontaneous murine tumor models.
    Di Luzio NR; McNamee RB; Williams DL; Gilbert KM; Spanjers MA
    Adv Exp Med Biol; 1979; 121(A):269-90. PubMed ID: 547726
    [No Abstract]   [Full Text] [Related]  

  • 40. Distribution of virus particles and mammary tumor virus antigens in mouse mammary tumors, transformed BALB-c mouse kidney cells, and GR ascites leukemia cells.
    Calafat J; Buijs F; Hageman PC; Links J; Hilgers J; Hekman A
    J Natl Cancer Inst; 1974 Oct; 53(4):977-92. PubMed ID: 4372372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.